104 related articles for article (PubMed ID: 32755656)
1. LRF/ZBTB7A conservation accentuates its potential as a therapeutic target for the hematopoietic disorders.
Chondrou V; Markopoulos GS; Patrinos GP; Kouraklis-Symeonidis A; Symeonidis A; Papachatzopoulou A; Sgourou A
Gene; 2020 Nov; 760():145020. PubMed ID: 32755656
[TBL] [Abstract][Full Text] [Related]
2. LRF Promotes Indirectly Advantageous Chromatin Conformation via
Chondrou V; Shaukat AN; Psarias G; Athanasopoulou K; Iliopoulou E; Damanaki A; Stathopoulos C; Sgourou A
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806029
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for human ZBTB7A action at the fetal globin promoter.
Yang Y; Ren R; Ly LC; Horton JR; Li F; Quinlan KGR; Crossley M; Shi Y; Cheng X
Cell Rep; 2021 Sep; 36(13):109759. PubMed ID: 34592153
[TBL] [Abstract][Full Text] [Related]
4. Impact of ZBTB7A hypomethylation and expression patterns on treatment response to hydroxyurea.
Chondrou V; Stavrou EF; Markopoulos G; Kouraklis-Symeonidis A; Fotopoulos V; Symeonidis A; Vlachaki E; Chalkia P; Patrinos GP; Papachatzopoulou A; Sgourou A
Hum Genomics; 2018 Oct; 12(1):45. PubMed ID: 30285874
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide DNA methylation profiles in hematopoietic stem and progenitor cells reveal overrepresentation of ETS transcription factor binding sites.
Hogart A; Lichtenberg J; Ajay SS; Anderson S; ; Margulies EH; Bodine DM
Genome Res; 2012 Aug; 22(8):1407-18. PubMed ID: 22684279
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional repression of lncRNA and miRNA subsets mediated by LRF during erythropoiesis.
Athanasopoulou K; Chondrou V; Xiropotamos P; Psarias G; Vasilopoulos Y; Georgakilas GK; Sgourou A
J Mol Med (Berl); 2023 Sep; 101(9):1097-1112. PubMed ID: 37486375
[TBL] [Abstract][Full Text] [Related]
7. The multi-faceted functioning portrait of LRF/ZBTB7A.
Constantinou C; Spella M; Chondrou V; Patrinos GP; Papachatzopoulou A; Sgourou A
Hum Genomics; 2019 Dec; 13(1):66. PubMed ID: 31823818
[TBL] [Abstract][Full Text] [Related]
8. Leukemia/lymphoma-related factor regulates oligodendrocyte lineage cell differentiation in developing white matter.
Dobson NR; Moore RT; Tobin JE; Armstrong RC
Glia; 2012 Sep; 60(9):1378-90. PubMed ID: 22615173
[TBL] [Abstract][Full Text] [Related]
9. Variants of ZBTB7A (LRF) and its β-globin gene cluster binding motifs in sickle cell anemia.
Shaikho EM; Habara AH; Alsultan A; Al-Rubaish AM; Al-Muhanna F; Naserullah Z; Alsuliman A; Qutub HO; Patra PK; Sebastiani P; Baltrusaitis K; Farrell JJ; Jiang Z; Luo HY; Chui DH; Al-Ali AK; Steinberg MH
Blood Cells Mol Dis; 2016 Jul; 59():49-51. PubMed ID: 27282567
[No Abstract] [Full Text] [Related]
10. Protection of CpG islands from DNA methylation is DNA-encoded and evolutionarily conserved.
Long HK; King HW; Patient RK; Odom DT; Klose RJ
Nucleic Acids Res; 2016 Aug; 44(14):6693-706. PubMed ID: 27084945
[TBL] [Abstract][Full Text] [Related]
11. Clusters of regulatory signals for RNA polymerase II transcription associated with Alu family repeats and CpG islands in human promoters.
Oei SL; Babich VS; Kazakov VI; Usmanova NM; Kropotov AV; Tomilin NV
Genomics; 2004 May; 83(5):873-82. PubMed ID: 15081116
[TBL] [Abstract][Full Text] [Related]
12. Structural basis for transcription factor ZBTB7A recognition of DNA and effects of ZBTB7A somatic mutations that occur in human acute myeloid leukemia.
Ren R; Horton JR; Chen Q; Yang J; Liu B; Huang Y; Blumenthal RM; Zhang X; Cheng X
J Biol Chem; 2023 Feb; 299(2):102885. PubMed ID: 36626981
[TBL] [Abstract][Full Text] [Related]
13. Emerging role of ZBTB7A as an oncogenic driver and transcriptional repressor.
Gupta S; Singh AK; Prajapati KS; Kushwaha PP; Shuaib M; Kumar S
Cancer Lett; 2020 Jul; 483():22-34. PubMed ID: 32348807
[TBL] [Abstract][Full Text] [Related]
14. Unusual sequence characteristics of human chromosome 19 are conserved across 11 nonhuman primates.
Harris RA; Raveendran M; Worley KC; Rogers J
BMC Evol Biol; 2020 Feb; 20(1):33. PubMed ID: 32106815
[TBL] [Abstract][Full Text] [Related]
15. Zbtb7a is a transducer for the control of promoter accessibility by NF-kappa B and multiple other transcription factors.
Ramos Pittol JM; Oruba A; Mittler G; Saccani S; van Essen D
PLoS Biol; 2018 May; 16(5):e2004526. PubMed ID: 29813070
[TBL] [Abstract][Full Text] [Related]
16. ZBTB7A links tumor metabolism to myeloid differentiation.
Redondo Monte E; Kerbs P; Greif PA
Exp Hematol; 2020 Jul; 87():20-24.e1. PubMed ID: 32525064
[TBL] [Abstract][Full Text] [Related]
17. Genomic organization of the human NFAT5 gene: exon-intron structure of the 14-kb transcript and CpG-island analysis of the promoter region.
Dalski A; Schwinger E; Zühlke C
Cytogenet Cell Genet; 2001; 93(3-4):239-41. PubMed ID: 11528118
[TBL] [Abstract][Full Text] [Related]
18. Dual promoter structure of ZFP106: regulation by myogenin and nuclear respiratory factor-1.
Grasberger H; Ye H; Mashima H; Bell GI
Gene; 2005 Jan; 344():143-59. PubMed ID: 15656981
[TBL] [Abstract][Full Text] [Related]
19. ZBTB7A suppresses glioblastoma tumorigenesis through the transcriptional repression of EPB41L5.
Jeong JH; Park SH; Kim H; Nam HY; Kim SH; Jeong M; Kong MJ; Son J; Jeong JE; Song JH; Kim SW; Choi KC
Exp Mol Med; 2023 Jan; 55(1):43-54. PubMed ID: 36596853
[TBL] [Abstract][Full Text] [Related]
20. KLF1 directly activates expression of the novel fetal globin repressor
Norton LJ; Funnell APW; Burdach J; Wienert B; Kurita R; Nakamura Y; Philipsen S; Pearson RCM; Quinlan KGR; Crossley M
Blood Adv; 2017 Apr; 1(11):685-692. PubMed ID: 29296711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
